
Key Takeaways
- Goldman Sachs MD Bonnie Herzog projected U.S. nicotine revenue of about $67B by 2035
- Cigarettes’ revenue share projected at 47% by 2035 as smoke-free expands
- Cigarettes seen falling from about 70% of the operating profit pool today to about 50% by 2035
- Smoke-free volumes projected to rise from about 48% today to about 75% by 2035
- Illicit e-vapor penetration estimated at about 70% today; expected to decline through 2035
- Nicotine pouches projected to nearly $11B in revenue by 2035; Zyn and Velo Plus referenced
2Firsts, March 4, 2026
According to CSP, New York-based Goldman Sachs Managing Director Bonnie Herzog said during a virtual session at CSP’s Convenience Retailing University in Austin, Texas, that the U.S. nicotine market is attractive and growing, with total revenue projected to reach roughly $67 billion by 2035. She said cigarettes are expected to make up a smaller portion of revenue (47%) while smoke-free revenue expands.

Herzog said that, given attractive unit economics, smoke-free products are expected to become the key driver of industry profit growth. She added that while cigarettes comprise about 70% of the operating profit pool today, their share is expected to fall to roughly 50% of profits by 2035.
On volumes, Herzog said smoke-free products make up roughly 48% of U.S. nicotine volumes today and she expects that number to rise to roughly 75% by 2035.
In the e-vapor category, Herzog said illicit e-vapor penetration is roughly 70% today and she expects it to fall through 2035. She said the continued prevalence of illicit e-vapor will keep weighing on growth of the formal/tracked channel within vapor, and she expects British American Tobacco to remain the largest branded player in e-vapor until there is greater enforcement on illicit products.
She also cited federal seizures in September, when HHS and CBP seized 4.7 million units of unauthorized e-cigarette products with an estimated retail value of $86.5 million.
Turning to nicotine pouches, Herzog said she expects the segment to grow to nearly $11 billion of revenue by 2035 and to become the second-largest category by volume in 2035, behind e-vapor.
She referenced Zyn, from Stamford, Connecticut-based Philip Morris International, as leading modern oral nicotine, and cited a Goldman Sachs fourth-quarter 2025 survey indicating Zyn gains were supported by promotions, including a free-can offering in September and multi-can discounts from October through November. She added that Velo Plus, from Winston-Salem, North Carolina-based Reynolds American Inc., a BAT subsidiary, has been a “fierce” competitor in the segment.
Image Source: CSP
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com







